Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma.
about
Role of H-Ras/ERK signaling in carbon nanotube-induced neoplastic-like transformation of human mesothelial cellsExpression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patientsFluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse modelsHuman bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasionAltered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamine.RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer.Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer.The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells.RREB1 transcription factor splice variants in urologic cancer.Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC)PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity.Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles.A lyophilized red grape pomace containing proanthocyanidin-rich dietary fiber induces genetic and metabolic alterations in colon mucosa of female C57BL/6J mice.Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesisGene expression profiling of chemically induced rat bladder tumors.Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Nucleic Acid Targeted Therapy: G4 Oligonucleotides Downregulate HRAS in Bladder Cancer Cells through a Decoy Mechanism.A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens.Persistence of Ha-ras-induced metastatic potential of SP1 mouse mammary tumors despite loss of the Ha-ras shuttle vector.HRAS is silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding property.A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.Cloning and overexpression of TGF-beta 1 cDNA in a mammary adenocarcinoma: in vitro and in vivo effects.Contribution of the intracellular domain of murine Fc-gamma receptor type IIB1 to its tumor-enhancing potential.Ribozyme-mediated cancer gene therapy.The murine Fc-gamma (Fc gamma) receptor type II B1 is a tumorigenicity-enhancing factor in polyoma-virus-transformed 3T3 cells.Molecular assessment of c-H-ras p21 expression in Helicobacter pylori-mediated gastric carcinogenesis.FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma.Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.H-ras mutation detection in bladder cancer by COLD-PCR analysis and direct sequencing.
P2860
Q23923553-9F88C43E-7C59-4E15-ADDD-D8D7D9F83C38Q24645597-9A693DC8-1190-4CC6-8230-E3389C2A984BQ27323143-B2AF2F0C-D5E4-4A5B-A5CE-BBE1D21F6025Q28350937-747B0B26-7EFB-4FF4-86A2-88118F9AB4B3Q30160400-E2A22591-503D-4B1D-959A-CA63FAEF8614Q30301104-7EFC0E61-3B3F-41C6-A5E5-2BC7C265D2B8Q30304937-72434F03-3C97-4F14-B17E-3D8475B50708Q30307781-AC434D83-5915-4476-954E-D63AC53648D5Q30426139-1B30D25E-D389-4C96-B36F-829EA58A679FQ30433431-109F377B-39F0-4ABD-9EA9-DC15E9AB578FQ30434033-427469BD-AA35-4362-84DD-6C84C26CF2A2Q33687975-F433D2D8-F806-4B99-99EF-30294F07013FQ33966775-D64D61CB-E9EA-44FB-B4AD-3E4FF6B75F6CQ35589281-9C56B959-4565-4E11-B6E8-86C8FC52622EQ35721181-73C886A7-B628-46BF-AB8C-5E500138D665Q36341182-427503E6-2059-47D4-B6AC-39354033401DQ36367297-5AE6CDB9-9D7C-4CEB-84DA-53D862E6EEB9Q37070130-F2D86901-4FE5-4089-A3CA-EAB57D1C1361Q37261876-FE178A22-553B-4B82-9F82-FA5945121C11Q38976432-3AD76E2A-B164-46D5-81FC-9AD09BCC9090Q40082035-43FAEF53-05D2-4D96-AEB6-F22BE51A7E72Q41147284-5CDD4F3E-EA4B-4F74-85A3-D0EC161CC9E5Q41159482-9A34F942-405C-4BE8-B5F0-9ED7B59A1E60Q41562210-23EA444E-0C0B-43BD-BFEC-9C2575E45D35Q42817384-0F076AB8-83D8-4191-8D8C-5FFED8E50F1DQ46749011-FD4E0DCD-B190-4433-AA60-6945CB1E0658Q52857898-9943F53B-F802-49A3-A365-9FB2D464BAEDQ53408393-44E53A64-6284-4D90-A247-292DD6055588Q54318310-96AEA969-3FFB-4D7C-9535-22FDCDB161A8
P2860
Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma.
description
1990 nî lūn-bûn
@nan
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Overexpression of normal and m ...... n transitional cell carcinoma.
@ast
Overexpression of normal and m ...... n transitional cell carcinoma.
@en
type
label
Overexpression of normal and m ...... n transitional cell carcinoma.
@ast
Overexpression of normal and m ...... n transitional cell carcinoma.
@en
prefLabel
Overexpression of normal and m ...... n transitional cell carcinoma.
@ast
Overexpression of normal and m ...... n transitional cell carcinoma.
@en
P2093
P2860
P356
P1476
Overexpression of normal and m ...... n transitional cell carcinoma.
@en
P2093
B J Fernandez
D Theodorescu
R S Kerbel
P2860
P304
P356
10.1073/PNAS.87.22.9047
P407
P577
1990-11-01T00:00:00Z